Co-occurring ADHD in young children with ASD: Precursors, detection, neural signatures, and early treatment
患有 ASD 的幼儿同时发生 ADHD:先兆、检测、神经特征和早期治疗
基本信息
- 批准号:9385863
- 负责人:
- 金额:$ 238.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-07 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAddressAffectAgeAge-MonthsAttentionAttention deficit hyperactivity disorderAttentional deficitAutistic DisorderBehaviorBehavior TherapyBehavioralBiologicalBiological MarkersBrainCaringCharacteristicsChildChildhoodClinicClinicalClinical TrialsComorbidityComputer Vision SystemsComputersDataData AnalysesDetectionDevelopmentDiagnosisDiseaseEarly DiagnosisEarly InterventionEarly treatmentEducationEngineeringEpidemiologyEthnic OriginEtiologyEyeGeneticGoalsHealthHealth Services ResearchHeterogeneityHigh PrevalenceHyperactive behaviorImpulsivityIndividualInterventionKnowledgeLifeLinkMeasuresMedical HistoryMethodsModelingMonitorMovementNeurobiologyNeurocognitiveNeurosciencesOutcomeParent-Child RelationsParentsPatientsPatternPharmacologyPhenotypePopulationPrimary Health CareProcessQuality of lifeRaceRecruitment ActivityResearchResearch InfrastructureResearch PersonnelRiskRisk FactorsSamplingSocial InteractionSocioeconomic StatusSourceSubgroupSymptomsTechnologyTemperamentTestingToddlerWorkautism spectrum disorderbaseclinical practicecohortcostdata managementdevelopmental psychologyearly childhoodeffective therapyhigh riskimprovedimproved outcomeinattentioninfancymodel developmentneuromechanismneurophysiologynoveloutreachpersonalized medicineprospectiverelating to nervous systemresponseroutine carescreeningsocialsocial attentionsocial engagementsocial learningstatisticstreatment responsetreatment strategy
项目摘要
ABSTRACT – Co-occurring ADHD in young children with ASD: Precursors, detection, neural signatures, and
early treatment
Attention deficit hyperactivity disorder (ADHD) occurs in ~40-60% of individuals with autism spectrum disorder
(ASD) and substantially contributes to poorer clinical outcomes. Yet, very little research has focused on the
overlap of ASD and ADHD during early childhood. Thus, little is known about how these two conditions co-
emerge early in life. Given the high prevalence and clinical impact of the comorbidity of ASD and ADHD, the
overall goal of the Duke Autism Center of Excellence is to characterize how co-occurring ADHD influences
early screening, neural signatures, developmental trajectories, and response to early treatment of young
children with ASD. Project 1 will characterize risk factors for and emergence of co-occurring ADHD symptoms
in young children at risk for ASD and examine how these symptoms influence early detection and progression
of ASD. This project will clarify why children who have co-occurring ADHD are diagnosed at a much later age
and inform more effective early detection strategies. Following a large sample of toddlers receiving routine care
in Duke pediatric primary clinics (N = ~ 2800 patients/year), Project 1 will prospectively identify children at risk
for ASD and collect data on risk factors, ADHD, and developmental outcomes. Project 2 will elucidate shared
and distinct neural signatures and attention-related biomarkers related to ASD and ADHD, examine the
functional impact of co-occurring ADHD in young children with ASD, and identify precursor characteristics
during infancy that are predictive of later emergence of comorbid ASD and ADHD. This project will characterize
children with ASD alone, ASD+ADHD, ADHD alone, and typically-developing children, using state-of-the-art
methods, including neurophysiology, eye-tracking, movement-tracking, and computer vision analysis. Project
3 will evaluate a novel early intervention model personalized for young children with ASD+ADHD that
pharmacologically addresses ADHD symptoms prior to initiating early behavioral intervention, and identify
changes in behavioral and neurophysiological activity that may underlie response to treatment. This project will
accomplish these goals by evaluating whether stimulant treatment (Adzenys-XR-ODT) augments the efficacy
of a parent-delivered behavioral intervention based on the Early Start Denver Model. This project will examine
whether changes in outcome are correlated with improvements in social attention, measured via eye-tracking
biomarkers, and social engagement during parent-child interaction. This project will also examine
neurophysiological changes underlying improvements in behavior. These projects will be supported by four
cores: Administrative Core, Recruitment and Assessment Core, Data Management and Analysis Core,
and Dissemination and Outreach Core. Functioning as a whole, the Duke Autism Center of Excellence will
offer the most comprehensive understanding to date of the impact of ADHD on young children with ASD,
providing important information that will allow for biologically informed and personalized methods for early
detection and treatment that could mitigate the negative impact of co-occurring ADHD on individuals with ASD.
摘要 – 患有 ASD 的幼儿同时发生 ADHD:前兆、检测、神经特征和
早期治疗
约 40-60% 的自闭症谱系障碍患者患有注意力缺陷多动障碍 (ADHD)
(自闭症谱系障碍)并导致较差的临床结果,然而,很少有研究关注这一点。
自闭症谱系障碍 (ASD) 和多动症 (ADHD) 在儿童早期有重叠,因此,我们对这两种疾病如何共同作用知之甚少。
鉴于 ASD 和 ADHD 合并症的高患病率和临床影响,
杜克大学自闭症卓越中心的总体目标是描述同时发生的多动症如何影响
早期筛查、神经特征、发育轨迹以及对年轻人早期治疗的反应
项目 1 将描述同时发生的 ADHD 症状的危险因素和出现情况。
对有 ASD 风险的幼儿进行研究,并研究这些症状如何影响早期发现和进展
该项目将阐明为什么患有多动症的儿童在很晚的年龄才被诊断出来。
并通过大量接受常规护理的幼儿样本,提供更有效的早期检测策略。
在杜克大学儿科初级诊所(N = ~ 2800 名患者/年),项目 1 将前瞻性地识别处于危险中的儿童
项目 2 将阐明 ASD 的风险因素、ADHD 和发展结果的数据。
以及与 ASD 和 ADHD 相关的独特神经特征和注意力相关生物标志物,检查
患有 ASD 的幼儿同时发生 ADHD 的功能影响,并确定先兆特征
该项目将描述婴儿期出现自闭症谱系障碍 (ASD) 和多动症 (ADHD) 共病的预测。
单独患有自闭症谱系障碍 (ASD) 的儿童、自闭症谱系障碍 (ASD) + 注意力缺陷多动症 (ADHD)、单独的注意力缺陷多动症 (ADHD) 以及正常发育的儿童,使用最先进的技术
方法,包括神经生理学、眼球追踪、运动追踪和计算机视觉分析项目。
3 将评估针对 ASD+ADHD 幼儿的个性化新型早期干预模型
在开始早期行为干预之前,从药物上解决 ADHD 症状,并确定
该项目将导致行为和神经生理活动的变化,这可能是治疗反应的基础。
通过评估刺激治疗 (Adzenys-XR-ODT) 是否增强疗效来实现这些目标
该项目将研究基于“早期开始丹佛模型”的家长提供的行为干预。
结果的变化是否与通过眼动追踪测量的社会注意力的改善相关
该项目还将研究生物标志物以及亲子互动期间的社会参与。
这些项目将得到四个项目的支持。
核心:行政核心、招聘与考核核心、数据管理与分析核心、
杜克大学自闭症卓越中心将作为一个整体发挥作用。
提供迄今为止最全面的关于注意力缺陷多动症(ADHD)对患有自闭症谱系障碍(ASD)幼儿的影响的了解,
提供重要信息,以便为早期诊断提供生物学信息和个性化方法
检测和治疗可以减轻同时发生的多动症对自闭症患者的负面影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Geraldine Dawson其他文献
Geraldine Dawson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Geraldine Dawson', 18)}}的其他基金
Novel Approaches to Infant Screening for ASD in Pediatric Primary Care
儿科初级保健中婴儿自闭症谱系障碍筛查的新方法
- 批准号:
10443752 - 财政年份:2019
- 资助金额:
$ 238.05万 - 项目类别:
Scalable Computational Platform For Active Closed-Loop Behavioral Coding in Autism Spectrum Disorder
用于自闭症谱系障碍主动闭环行为编码的可扩展计算平台
- 批准号:
10440249 - 财政年份:2019
- 资助金额:
$ 238.05万 - 项目类别:
Novel Approaches to Infant Screening for ASD in Pediatric Primary Care
儿科初级保健中婴儿自闭症谱系障碍筛查的新方法
- 批准号:
10227331 - 财政年份:2019
- 资助金额:
$ 238.05万 - 项目类别:
Novel Approaches to Infant Screening for ASD in Pediatric Primary Care
儿科初级保健中婴儿自闭症谱系障碍筛查的新方法
- 批准号:
10018110 - 财政年份:2019
- 资助金额:
$ 238.05万 - 项目类别:
Novel Approaches to Infant Screening for ASD in Pediatric Primary Care
儿科初级保健中婴儿自闭症谱系障碍筛查的新方法
- 批准号:
10670242 - 财政年份:2019
- 资助金额:
$ 238.05万 - 项目类别:
Scalable Computational Platform For Active Closed-Loop Behavioral Coding in Autism Spectrum Disorder
用于自闭症谱系障碍主动闭环行为编码的可扩展计算平台
- 批准号:
9791518 - 财政年份:2019
- 资助金额:
$ 238.05万 - 项目类别:
Neural signatures, developmental precursors, and outcomes in young children with ASD and ADHD
患有 ASD 和 ADHD 的幼儿的神经特征、发育前兆和结果
- 批准号:
10227712 - 财政年份:2017
- 资助金额:
$ 238.05万 - 项目类别:
Duke Autism Center of Excellence: A translational digital health and computational approach to early identification, outcome monitoring, and biomarker discovery in autism
杜克大学自闭症卓越中心:用于自闭症早期识别、结果监测和生物标志物发现的转化数字健康和计算方法
- 批准号:
10523403 - 财政年份:2017
- 资助金额:
$ 238.05万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 238.05万 - 项目类别:
MAIT cells in lupus skin disease and photosensitivity
MAIT 细胞在狼疮皮肤病和光敏性中的作用
- 批准号:
10556664 - 财政年份:2023
- 资助金额:
$ 238.05万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 238.05万 - 项目类别:
The role of core circadian regulator Bmal1 in axonal regeneration and nerve repair
核心昼夜节律调节因子 Bmal1 在轴突再生和神经修复中的作用
- 批准号:
10677932 - 财政年份:2023
- 资助金额:
$ 238.05万 - 项目类别:
Translational Research and Implementation Science for Nurses (TRAIN) Program 2.0
护士转化研究和实施科学 (TRAIN) 计划 2.0
- 批准号:
10680769 - 财政年份:2023
- 资助金额:
$ 238.05万 - 项目类别: